Search
Technologies_Flyer_BIO_2022.pdf
Oncology_Flyer_BIO_2022.pdf
Respiratory_Flyer_BIO-2021.pdf
CNS_Flyer_BIO-2021.pdf
Immunology_Flyer_BIO-2021.pdf
2015 09 18 BI in Oncology Backgrounder_6.0_ohne694.pdf
BI 694 backgrounder.pdf
ww_contacts_2021_06_bis-2021-06-18.pdf
WW_Contacts_BIO_June_2022_V2.pdf
CardioMetabolic_Flyer_BIO_2022.pdf
Boehringer_Ingelheim_Biosimilars.pdf
BI Newsletter_Dec_2016_FINAL.pdf
How BI Supports Grass Roots Innovation
Hear from life-science entrepreneurs about how we are supporting early-stage science through our innovative Grass Roots program.
Combivent® Respimat®
A combination of a short-acting anticholinergic and beta-adrenergic for the management of reversible bronchospasms associated with obstructive airway diseases in patients requiring more than one bronchodilator.
Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint
Rabisin® / Imrab®
Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.
BIVF funding more than doubled to 250 M€
Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
Rabisin® / Raboral V-RG®
Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.
Recombitek®
Recombitek® offers a complete line of canine vaccines against distemper, major circulating strains CPV-2a, 2b, 2c, prevention of disease and shedding against leptospirosis.
Glyxambi®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with both empagliflozin and linagliptin is appropriate (US).
Praxbind®
Praxbind® is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa® (dabigatran etexilate) when rapid reversal of its anticoaculant effects is required: for emergency surgery/urgent procedures; in life-threa
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
BI_PharmAccess_launch_digital_healthcare_program
Boehringer Ingelheim and PharmAccess launch a new mobile support program „Tiba Yako“ to empower patients to become more aware, access care and take charge of their disease management